ENDV (Endonovo Therapeutics) Accounts Payable: $3.36 Mil (As of Jun. 2025)


What is Endonovo Therapeutics Accounts Payable?

Endonovo Therapeutics ENDV -99.00% Accounts Payable is $3.36 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Endonovo Therapeutics's Accounts Payable for the quarter that ended in Jun. 2025 was $3.36 Mil.

Endonovo Therapeutics's quarterly Accounts Payable declined from Dec. 2024 ($3.43 Mil) to Mar. 2025 ($3.36 Mil) and declined from Mar. 2025 ($3.36 Mil) to Jun. 2025 ($3.36 Mil).

Endonovo Therapeutics's annual Accounts Payable increased from Dec. 2022 ($0.88 Mil) to Dec. 2023 ($1.08 Mil) and increased from Dec. 2023 ($1.08 Mil) to Dec. 2024 ($3.43 Mil).

Endonovo Therapeutics Accounts Payable Related Terms

Endonovo Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Accounts Payable Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.66 0.88 1.08 3.43

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.13 3.43 3.36 3.36

Endonovo Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $3.36 Mil mean?
Endonovo Therapeutics (ENDV) has a Accounts Payable of $3.36 Mil as of Jun. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Endonovo Therapeutics and its competitors.
Is Endonovo Therapeutics' Accounts Payable too high?
Endonovo Therapeutics' current Accounts Payable is $3.36 Mil.
How does Endonovo Therapeutics' Accounts Payable compare to RGBP and SIGY?
Endonovo Therapeutics' Accounts Payable of $3.36 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Accounts Payable is $3.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Accounts Payable of $3.36 Mil. The current Accounts Payable is $3.36 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Accounts Payable is $3.36 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.